Détail de l'auteur
Auteur I. GIRAUDON |
Documents disponibles écrits par cet auteur (48)
Article : Périodique
A. M. DINES ; D. M. WOOD ; C. YATES ; F. HEYERDAHL ; K. E. HOVDA ; I. GIRAUDON ; R. SEDEFOV ; P. I. DARGAN ; Euro-DEN Research Group |CONTEXT: Despite the potential for recreational drugs and new psychoactive substances (NPSs) to cause significant morbidity and mortality, there is limited collection of systematic data on acute drug/NPS toxicity in Europe. OBJECTIVE: To report[...]Article : Périodique
G. MENA ; I. GIRAUDON ; E. ALVAREZ ; J. M. CORKERY ; J. MATIAS ; K. GRASAASEN ; N. LLORENS ; P. GRIFFITHS ; J. VICENTE |Background: Cocaine-related health consequences are difficult to observe. Data on drug users in health-emergency settings may be a useful source of information on consequences that are not visible via other information sources. Methods: Thirty[...]Article : Périodique
P. Y. BELLO ; I. GIRAUDON ; M. J. PARENT ; G. CAGNI ; J. M. DELILE ; FRIGAUX H. ; S. MERLE ; L. PLANCKE ; VILLECHENOUX J.-M. ; YIM J.-P. |Le contenu des produits du cannabis (herbe, résine, huile), dont le principe actif est le delta-neuf-tétra-hydro-cannabinol (THC), est une question débattue en France et en Europe. Les seules données disponibles en France étaient, jusqu'à présen[...]Article : Périodique
F. HEYERDAHL ; K. E. HOVDA ; I. GIRAUDON ; C. B. YATES ; A. M. DINES ; R. SEDEFOV ; D. M. WOOD ; P. I. DARGAN |BACKGROUND: The number of new (novel) psychoactive substances (NPS) available in the illegal market is increasing; however, current monitoring of the drug situation in Europe focuses mainly on classical drugs of abuse, with limited emphasis on c[...]Article : Périodique
I. GIRAUDON ; D. HEDRICH ; A. PIRONA ; A. NOOR ; J. MOUNTENEY |FRANÇAIS : Avec au moins 9 100 overdoses, ou décès provoqués par la drogue, en Europe en 2016 - en augmentation de 4% depuis 2015 - la consommation de drogues illicites représente un véritable défi de santé public (EMCDDA European Drug Report 2[...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; F. MATHIS ; D. HEDRICH ; J. VICENTE ; A. NOOR | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deat[...]Rapport
On 30 September and 1 October 2021, the EMCDDA brought together more than 60 European and international experts for the annual meeting on the key indicator Drug-related deaths. The online meeting provided a space for sharing and discussing new d[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; J. MATIAS ; L. MONTANARI ; D. HEDRICH ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug use, in particular high-risk drug use, is one of the major causes of avoidable mortality among young people in Europe, both directly through overdose and indirectly through drug-related diseases, accidents, violence and suicide. The Drug-r[...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; A. M. DINES ; N. SINGLETON ; A. NOOR ; P. I. DARGAN ; D. WOOD | Lisbon : OEDT / EMCDDA | Technical reports | 2020ENGLISH: This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of th[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; L. WIESSING ; E. KALAMARA ; D. HEDRICH ; R. SIMON ; K. PALCZAK ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections among people who inject drugs. This group is a key population affected [...]Article : Périodique
Problem drug use in pregnancy affects a sizeable population in Europe. A literature review was carried out of articles in PubMed, European Monitoring Centre for Drugs and Drug Addiction publications, and related documents in order to assess publ[...]Article : Périodique
Ecstasy et autres produits de synthèse en France. Etat des lieux issu du dispositif SINTES 1999-2002
FRANÇAIS : Crée en 1999, dans le cadre des orientations du Plan triennal de lutte contre la drogue et de prévention des dépendances, SINTES (Système national de surveillance des toxiques et substances) délivre des informations sur les drogues d[...]Rapport
The protocol establishes harmonised criteria to extract process and report cases, based on the information available, at the end point of the chain of certification/ascertainment procedures, at different mortality registries: General Mortality R[...]Périodique
OEDT = EMCDDA ; I. GIRAUDON ; G. MENA ; J. MATIAS ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014This study reveals the substantial levels of morbidity related to cocaine use, translated into the large number of cocaine cases seen in various emergency settings in European countries. This health burden is often not captured by other traditio[...]Article : Périodique
O. MIRO ; P. I. DARGAN ; D. M. WOOD ; A. M. DINES ; C. YATES ; F. HEYERDAHL ; K. E. HOVDA ; I. GIRAUDON ; Euro-DEN Plus Research Group ; M. GALICIA |Objective: To analyse the epidemiology, clinical picture and emergency department (ED) management of a large series of patients who presented to European EDs after cocaine consumption, comparing data from powder (C-1 group) and crack (C-2 group)[...]Article : Périodique
ENGLISH : The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Associa[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. EVANS-BROWN ; I. GIRAUDON | Lisbon : OEDT / EMCDDA | Technical reports | 2012The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9-10 October 2012. The aim of the study was to increase understanding of the availability [...]Article : Périodique
Fentanyl is a synthetic opioid analgesic historically used as a pain reliever and an anaesthetic. Recent concerns have arisen around the illicit use of fentanyl and its analogues in a number of European countries, linked to their high potency an[...]Rapport
OEDT = EMCDDA ; M. HICKMAN, Éditeur scientifique ; N. K. MARTIN, Éditeur scientifique ; I. GIRAUDON ; L. WIESSING ; D. HEDRICH ; E. KALAMARA ; P. GRIFFITHS ; R. SIMON | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016FRANÇAIS : L'hépatite C est une maladie infectieuse du foie causée par le virus de l'hépatite C (VHC) qui peut être transmis par le sang. Environ 115 millions de personnes à travers le monde ont été infectées à un moment donné de leur vie par l[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2017This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]Rapport
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Ad hoc publication | 2021Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]Article : Périodique
C. LEAPER ; A. M. DINES ; P. I. DARGAN ; C. YATES ; K. E. HOVDA ; F. HEYERDAHL ; I. GIRAUDON ; D. M. WOOD ; Euro-DEN Plus Research Group |Over the last few years, there have been increasing reports of the potential for dependence and misuse of gabapentinoids such as pregabalin. Recent data from the UK have demonstrated an increase in 'gabapentinoid' deaths from 1 death in 2009 to [...]Bulletin : Périodique
Tendances, n°34 - Février 2004 - Informations récentes sur les produits de synthèse circulant en France. Les données du dispositif socio sanitaire de SINTES de juillet 2002 à septembre 2003
I. GIRAUDON ; P. Y. BELLO ; Dispositif SINTES | 2004FRANÇAIS : Les premiers résultats du dispositif SINTES juin 1999 - juin 2002 ont été présentés dans le numéro 32 de Tendances. Cette nouvelle livraison propose une mise à jour des observations faites par le réseau socio-sanitaire pour la pério[...]Article : Périodique
T. SEYLER ; I. GIRAUDON ; A. NOOR ; J. MOUNTENEY ; P. GRIFFITHS |This paper addresses the question of whether Europe is facing an opioid epidemic and utilises data from the European monitoring system on opioid use, harms and availability, to help assess the situation. Data sources covering the last decade on [...]Article : Périodique
ENGLISH : The French National Identification System for Drugs and Other Substances (SINTES) is an original scheme gathering analytical information for synthetic drugs, both through police and customs' seizures in the entire country and collect[...]